Overview

A Study In Patients With Type 2 Diabetes Mellitus

Status:
Completed
Trial end date:
2006-10-31
Target enrollment:
Participant gender:
Summary
This study evaluates the effect of medicines for type 2 diabetes and lipids control. This study will require about 6 office visits for lab tests and examinations. All study related medicines and medical examinations will be provided at no cost to the subjects.
Phase:
Phase 3
Details
Lead Sponsor:
GlaxoSmithKline